---
name: Enable Biotech Ltd
slug: enablebiotech
site: cdmo
website_domain: enablebiotech.com
summary: Enable Biotech provides clinical GMP manufacturing for cell therapies, exosome therapies, and gene therapies, with SwissMedic accreditation pending for gene therapy operations as of summer 2024. Headquartered in Zug, Switzerland.
tagline: Clinical GMP manufacturing for cell, gene, and exosome therapies
founded_year: 2023
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: CH
tier2_domain_verified: false
updated_at: 2026-07-05T07:01:11.158Z
services_count: 4
modalities_count: 2
indications_count: 0
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Enable Biotech Ltd

Clinical GMP manufacturing for cell, gene, and exosome therapies

Listed on cdmo.directory.

## Summary

Enable Biotech provides clinical GMP manufacturing for cell therapies, exosome therapies, and gene therapies, with SwissMedic accreditation pending for gene therapy operations as of summer 2024. Headquartered in Zug, Switzerland.

## At a glance

- Founded: 2023
- HQ country: CH

## Services

- Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- CMC Regulatory Submission Support

## Modalities

- Cell Therapy
- Gene Therapy

## Locations

- Headquarters, Zug, Switzerland

## Long description

Enable Biotech Ltd, founded in 2023 in Zug, Switzerland, specializes in custom development and clinical GMP manufacturing of advanced therapy medicinal products (ATMPs) and exosome therapies. The company offers clinical GMP manufacturing services for cell therapies and exosome therapies, with gene therapy manufacturing capabilities added as of summer 2024 (pending SwissMedic accreditation).

_Profile last updated: 2026-07-05T07:01:11.158Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.